SOCS4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.520800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.778600E-01
Normal-vs-Stage2
6.386800E-01
Normal-vs-Stage3
2.016200E-01
Normal-vs-Stage4
6.360000E-01
Stage1-vs-Stage2
9.618600E-01
Stage1-vs-Stage3
1.512360E-02
Stage1-vs-Stage4
2.516800E-01
Stage2-vs-Stage3
5.80139999999396E-05
Stage2-vs-Stage4
1.500410E-01
Stage3-vs-Stage4
6.454200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.524200E-01
Normal-vs-AfricanAmerican
9.260000E-01
Normal-vs-Asian
2.579800E-01
Caucasian-vs-AfricanAmerican
6.779600E-01
Caucasian-vs-Asian
1.666990E-01
AfricanAmerican-vs-Asian
2.652800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.243000E-01
Normal-vs-Female
7.102800E-01
Male-vs-Female
6.870200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.689600E-01
Normal-vs-Age(41-60Yrs)
9.212000E-01
Normal-vs-Age(61-80Yrs)
5.185200E-01
Normal-vs-Age(81-100Yrs)
1.893640E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.563400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.582400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.887230E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.600300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.815740E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.214800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.448200E-01
Normal-vs-Daily Drinker
2.097400E-01
Normal-vs-Weekly Drinker
6.904000E-01
Normal-vs-Occasional Drinker
9.777200E-01
Normal-vs-Social Drinker
9.824400E-01
Non Drinker-vs-Daily Drinker
4.343800E-01
Non Drinker-vs-Weekly Drinker
5.490800E-01
Non Drinker-vs-Occasional Drinker
5.825600E-02
Non Drinker-vs-Social Drinker
1.818650E-01
Daily Drinker-vs-Weekly Drinker
2.751800E-01
Daily Drinker-vs-Occasional Drinker
1.805650E-02
Daily Drinker-vs-Social Drinker
5.380200E-02
Weekly Drinker-vs-Occasional Drinker
4.011200E-01
Weekly Drinker-vs-Social Drinker
4.914800E-01
Occasional Drinker-vs-Social Drinker
9.981800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.259800E-01
Normal-vs-Grade 2
1.335970E-01
Normal-vs-Grade 3
1.827240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.254200E-01
Grade 1-vs-Grade 3
7.785400E-01
Grade 1-vs-Grade 4
3.259800E-01
Grade 2-vs-Grade 3
5.524600E-01
Grade 2-vs-Grade 4
1.335970E-01
Grade 3-vs-Grade 4
1.827240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.650000E-01
Normal-vs-NonDiabetic
6.096600E-01
Diabetic-vs-NonDiabetic
2.202200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.138950E-01
Normal-vs-NoPancreatitis
6.140200E-01
Pancreatitis-vs-NoPancreatitis
1.051360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.846600E-01
Normal-vs-N1
6.564800E-01
N0-vs-N1
9.786000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.744600E-01
Normal-vs-TP53-NonMutant
7.790400E-01
TP53-Mutant-vs-TP53-NonMutant
9.568200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
